Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Atorvastatin for eradication of Helicobacter pylori
IRCT20161205031252N7Phase 4Completed
- Sponsor
- Qom University of Medical Sciences
- Start
- May 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of atorvastatin in Helicobacter pylori infection, sponsored by Qom University of Medical Sciences. Started May 2018; status: completed.
02
Drugs
atorvastatin
03
Conditions
Helicobacter pylori infection
Beyond the preview
Go deeper on IRCT20161205031252N7.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20161205031252N7.